Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BCTX
BCTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BCTX News
BriaCell Expands Clinical Trial Network with NYU Langone Health
3d ago
Newsfilter
BriaCell Receives FDA Clearance for Clinical Study of Bria-BRES+
4d ago
Newsfilter
BriaCell to Present Clinical Data at 2026 ASCO Annual Meeting
Apr 27 2026
Newsfilter
Bria-OTS+ Platform Shows Promising Advances in Cancer Immunotherapy
Apr 21 2026
Newsfilter
BriaCell Presents Positive Clinical Data at AACR 2026
Apr 20 2026
Newsfilter
BriaCell to Present Four Research Abstracts at AACR Annual Meeting
Mar 10 2026
Newsfilter
BriaCell and BriaPro Enter sCD80 Licensing Agreement
Feb 18 2026
Newsfilter
BRIACELL AND BRIAPRO SIGN ASSET PURCHASE AGREEMENT FOR EXCLUSIVE LICENSE OF SOLUBLE CD80
Feb 18 2026
moomoo
BriaCell's Phase 3 Study Receives Fifth Positive DSMB Recommendation
Feb 17 2026
Newsfilter
BriaCell Treatment Shows Significant Efficacy in Cancer Patients
Jan 28 2026
Newsfilter
BriaCell's New Therapy Significantly Extends Survival in Breast Cancer Patients
Jan 27 2026
Newsfilter
U.S. Retail Sales Rise 0.6% MoM, Tech Stocks Decline
Jan 14 2026
Benzinga
Bank of America Reports Q4 Net Income of $7.6 Billion, Exceeding Expectations
Jan 14 2026
Benzinga
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1%
Jan 14 2026
Benzinga
BriaCell Therapeutics Prices Public Offering at $5.59 per Unit for $30 Million
Jan 14 2026
NASDAQ.COM
BriaCell Therapeutics Prices $30 Million Offering Amid 53.75% Stock Plunge
Jan 14 2026
Benzinga
Show More News
